Article
Clostridium perfringens Enterotoxin as a Novel-Targeted Therapeutic for Brain Metastasis
1 Sept 2007
Abstract excerpt
Brain metastasis is the most commonly occurring intracranial tumor whose incidence seems to be increasing. With standard therapy, the average survival time of patients is approximately 8 months, and treatment often leads to neurologic dysfunction in long-term survivors, emphasizing the need for novel therapeutics. Clostridium perfringens enterotoxin (CPE) has recently been shown to rapidly and specifically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
